Patent classifications
A61B5/4082
PEG SENSING APPARATUS AND METHODS OF USE
A movement-assessment device and methods for using the testing device includes a peg board device having a plurality of apertures on a top surface, and a plurality of photo-optical gate sensors. A computing device, comprising a touchscreen interface, communicates with the peg board device.
SYSTEM AND METHOD FOR MEASURING PHYSIOLOGICALLY RELEVANT MOTION
A system for measuring and monitoring physiologically relevant motion of a subject includes at least a motion sensor to measure movement of the subject and produce a series of movement data representing the movement of the subject over a period of time. The system also includes at least a biometric sensor to simultaneously measure biometrics of the subject and produce a series of biometric values of the subject over the period of time. The system is configured to determine a noise-to-signal ratio for the series of movement data as a function of biometric intervals in the series of biometric values and identify at least a portion of the series of movement data as corresponding to a physiologically relevant biorhythm. The system can be used to diagnose and monitor a disease or disorder, including a neurological disorder or a traumatic brain injury.
Device and method to activate cell structures by means of electromagnetic energy
An implantable device for implantation in a human body or animal body. The device includes an energy source, an energy storage device, and an electronics unit. Further, an actuator is coupled with the energy storage device and it is configured to emit electromagnetic waves by discharging the energy storage device.
User device based Parkinson's disease detection
A method and user device for determining a unified Parkinson's disease rating scale (UPDRS) value associated with a user of the user device include obtaining video data associated with a movement of a body part of the user. The UPDRS value is determined using a model and the video data associated with the movement of the body part of the user. The UPDRS value is provided to permit an evaluation of the user based on the UPDRS value.
Detection of hypokinetic and hyperkinetic states
The present invention relates to an automated method of determining a kinetic state of a person. The method obtains accelerometer data from an accelerometer worn on an extremity of the person and processes the accelerometer data to determine a measure for the kinetic state. The present invention further relates to a device for determining a kinetic state of a person. The device comprises a processor configured to process data obtained from an accelerometer worn on an extremity of the person and to determine from the data a measure for the kinetic state. In the method and system the kinetic state is at least one of bradykinesia, dyskinesia, and hyperkinesia.
Method for treating anxiety disorders
A method for treating anxiety disorders may include applying a first pair of electrodes on the left side of a subject's head and a second pair of electrodes on the right side of the subject's head; applying a first stimulus carrier of a first magnitude to the first pair of electrodes and a second stimulus carrier of a second magnitude to the second pair of electrodes, wherein the first and second stimulus carriers combine to produce a stimulus having a frequency between 1 Hz and 1 kHz; and steering the stimulus toward the subject's left amygdala.
Device and method for examining a phase distribution used to determine a pathological interaction between different areas of the brain
A device for examining a pathological interaction between different brain areas, including a stimulation unit, which administers identical stimuli to a patient in a sequential manner, wherein the stimuli stimulate neurons of the patient in the brain areas to be examined, a measuring unit for recording measurement signals that represent a neural activity of the stimulated neurons, and a control and analysis unit for controlling the stimulation unit and for analyzing the measurement signals. The control and analysis unit transforms the measurement signals into the complex plane, examines the distribution of the phases of stimuli of the measurement signals absorbed by the measuring unit in response to the stimuli delivered to the patient, and determines the probability, with which the phase distribution differs from a uniform distribution, in order to ascertain whether a pathological interaction between the brain areas exists.
AUTOMATED ASSESSMENT OF COGNITIVE AND SPEECH MOTOR IMPAIRMENT
The application relates to devices and methods for assessing cognitive impairment and/or speech motor impairment in a subject. The method comprises analysing a voice recording from a word- reading test obtained from the subject by identifying a plurality of segments of the voice recording that correspond to single words or syllables and determining the number of correctly read words in the voice recording and/or the speech rate associated with the recording. Determining the correct number of words in the recording may comprise computing one or more Mel-frequency cepstral coefficients (MFCCs) for the segments, clustering the resulting vectors of values into n clusters, wherein each cluster has n possible labels, predicting a sequence of words in the voice recording using the labels associated with the clustered vectors of values, performing a sequence alignment between the predicted sequence of words and the sequence of words used in the word reading test, selecting the labels that result in the best alignment and counting the number of matches in the alignment. The devices and methods find use in the diagnosis and monitoring of diseases or disorders such as neurological disorders.
DEVICE FOR EFFECTIVE NON-INVASIVE DESYNCHRONIZING NEUROSTIMULATION
A device that suppresses a pathological synchronous and oscillatory neuron activity, and includes a non-invasive stimulation for stimulation, using stimuli, of neurons in the patient's brain and/or spinal cord, where those neurons are showing pathologically synchronous and oscillatory neuron activity, and the stimuli are designed to suppress are this activity when administered to the patient. Moreover, a measuring unit records measurement signals reflecting the neuron activity of the stimulated neurons and a control and analysis unit controls the stimulation unit to administer stimuli, check the success of stimulation based on the measurement, and, if the stimulation success is not sufficient, insert one or more stimulation breaks in the application of the stimuli or extend one or more stimulation breaks, where no stimuli that could suppress the pathological synchronous and oscillatory neuron activity are applied during the stimulation breaks.
SYSTEM AND METHOD FOR REMOTE MOTOR AND SENSORY FUNCTION TESTING
A system for remote motor and sensory function testing may involve use of patent and clinician computing devices, a patient testing device, and a clinician control device. A Remote Testing System (RTS) may coordinate displays of information among the devices in support of a test. A clinician or the RTS may cause display of instructions for guiding a patient in using the patient testing device. A clinician may receive feedback from the patient's interaction during the test session, or during a later session. The clinician control device may be used to control functioning of the patient testing device, in support of the test. The clinician control device may provide haptic or other feedback during the test session or during a later session. The system may track patient performance across multiple sessions and initiate follow-up test sessions as a result of data gathered in one or more prior test sessions.